Skip to main content
Premium Trial:

Request an Annual Quote

Salk Institute, Marburg University Join Thermo's RNAi Global Initiative

NEW YORK (GenomeWeb News) - The Salk Institute for Biological Sciences and the University of Marburg have joined the RNAi Global Initiative, Thermo Fisher Scientific said today.
 
Thermo Fisher described the initiative as an effort to pioneer whole-genome RNAi screening and to develop common research standards and share information to advance RNAi gene-silencing techniques.
 
The Salk Institute for Biological studies is expanding its genome-wide screening center, which will study cancer, metabolism, aging and basic and applied neurobiology, systems biology and plant research, Thermo Fisher said.
 
A researcher at the University of Marburg will study the MYC oncogene, which plays a role in many human cancers. The Marburg research will include whole-genome siRNA screening to hunt for gene targets that may assist in developing cancer drugs.
 
The RNAi Global Initiative now counts 23 research institutions in 11 different nations among its members, Thermo Fisher said.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.